A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Pfizer Inc stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 243,824 shares of PFE stock, worth $6.25 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
243,824
Previous 183,824 32.64%
Holding current value
$6.25 Million
Previous $5.14 Million 37.2%
% of portfolio
0.18%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $1.66 Million - $1.88 Million
60,000 Added 32.64%
243,824 $7.06 Million
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $309,561 - $362,748
-12,255 Reduced 6.25%
183,824 $5.14 Million
Q1 2024

May 09, 2024

SELL
$25.89 - $29.73 $78,498 - $90,141
-3,032 Reduced 1.52%
196,079 $5.44 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $6.24 Million - $8.1 Million
-238,731 Reduced 54.52%
199,111 $5.73 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $27.9 Million - $32.6 Million
-868,995 Reduced 66.5%
437,842 $14.5 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $23.5 Million - $27.2 Million
651,477 Added 99.41%
1,306,837 $47.9 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $1.51 Million - $1.97 Million
38,458 Added 6.23%
655,360 $26.7 Million
Q4 2022

Feb 14, 2023

BUY
$41.75 - $54.5 $5.82 Million - $7.6 Million
139,450 Added 29.21%
616,902 $31.6 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $1.11 Million - $1.36 Million
-25,372 Reduced 5.05%
477,452 $20.9 Million
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $7.41 Million - $8.78 Million
-159,210 Reduced 24.05%
502,824 $26.4 Million
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $5.4 Million - $6.69 Million
118,075 Added 21.71%
662,034 $34.3 Million
Q4 2021

Feb 11, 2022

BUY
$41.32 - $61.25 $2.22 Million - $3.29 Million
53,765 Added 10.97%
543,959 $32.1 Million
Q3 2021

Nov 04, 2021

BUY
$39.25 - $50.42 $1.11 Million - $1.42 Million
28,162 Added 6.1%
490,194 $21.1 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $4.19 Million - $4.75 Million
116,644 Added 33.77%
462,032 $18.1 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $2.54 Million - $2.86 Million
-75,742 Reduced 17.99%
345,388 $12.5 Million
Q4 2020

Feb 11, 2021

SELL
$33.47 - $42.56 $5.21 Million - $6.62 Million
-155,630 Reduced 26.98%
421,130 $15.5 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $218,344 - $256,168
6,877 Added 1.21%
576,760 $21.2 Million
Q2 2020

Aug 12, 2020

SELL
$30.12 - $36.54 $272,435 - $330,504
-9,045 Reduced 1.56%
569,883 $18.6 Million
Q1 2020

May 08, 2020

SELL
$27.03 - $38.62 $4.25 Million - $6.08 Million
-157,406 Reduced 21.38%
578,928 $18.9 Million
Q4 2019

Feb 13, 2020

SELL
$32.92 - $37.36 $4.58 Million - $5.2 Million
-139,202 Reduced 15.9%
736,334 $28.9 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $2.88 Million - $3.73 Million
88,506 Added 11.25%
875,536 $31.5 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $1.18 Million - $1.33 Million
32,001 Added 4.24%
787,030 $34.1 Million
Q1 2019

May 14, 2019

SELL
$37.5 - $41.2 $992,962 - $1.09 Million
-26,479 Reduced 3.39%
755,029 $32.1 Million
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $217,009 - $247,414
-5,641 Reduced 0.72%
781,508 $34.1 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $4.5 Million - $5.45 Million
130,416 Added 19.86%
787,149 $34.7 Million
Q2 2018

Aug 10, 2018

SELL
$32.98 - $35.16 $2.34 Million - $2.49 Million
-70,907 Reduced 9.74%
656,733 $23.8 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $1.2 Million - $1.4 Million
-37,722 Reduced 4.93%
727,640 $25.8 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $604,500 - $641,395
-18,175 Reduced 2.32%
765,362 $27.7 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $24.3 Million - $26.8 Million
783,537
783,537 $28 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $144B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.